[Ip-health] The Economist- The new drug war: Hard pills to swallow

Joel Lexchin jlexchin at yorku.ca
Fri Jan 3 09:30:00 PST 2014

I definitely agree with the notion that there is the idea of ransom. There is no justification for the prices of some of the drugs based on their R&D costs. The price is how much desperate people will pay. I’ve attached a Powerpoint slide that illustrates this. As you can see there is about a two fold difference in the R&D cost of different classes of drugs but about a 30 fold difference in annual costs.

Joel Lexchin
Joel Lexchin MD
School of Health Policy and Management
Faculty of Health
York University
4700 Keele St. 
Toronto ON 
Canada M3J 1P3
Tel:		+416-736-2100 x 22119
Fax:		+416-736-5227
E mail:	jlexchin at yorku.ca	

More information about the Ip-health mailing list